Operating Expenses Cambiamento Data
AbbVie USD 11.11B 540M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Ardelyx USD 48.99M 10.04M 2023-09
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Celldex Therapeutics USD 51.76M 9M 2023-12
Curis USD 15.2M 866K 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Incyte USD 826.07M 121.75M 2023-12
Life Technologies USD 12.97M 590K 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Xoma USD 6.62M 998K 2023-09



Xoma Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.